| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e253661ef0079638605fe5e327287a8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
2005-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae5892ab3a9dd7d3b597063ac4fd99a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c72abee410e73087defebe934a96688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68838210c2212eef702372004b89af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cff82345bc36fdc97ac8695fc03fb663 |
| publicationDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1778276-A1 |
| titleOfInvention |
Tnf-binding protein-1 in the treatment of psoriasis |
| abstract |
The treatment of psoriasis by administering an anti-TNF-alpha agent is here described. Such a treatment is performed according to specific doses, regimens and route of administration. In particular the anti-TNF-alpha agent is recombinant human TNF-binding protein-1 (r-hTBP-1) and the psoriasis is defined as moderate to severe or associated with psoriatic arthritis. |
| priorityDate |
2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |